SpicyIP

SEPTEMBER 11, 2023

First thing first, let’s unfold the case: The case involves a writ petition challenging the abandonment of a patent application and praying for its restoration. Here, the background is that the Petitioner hired Mr. Naveen Chaklan of M/s Delhi Intellectual Property LLP to deal with his patent application.

Government 105

Government Trademark Patent Patent Application 105

Kashishipr

DECEMBER 28, 2021

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. However, in this case, it is imperative to note that determining the scope of a patent is not easy. Bottom Line.

IP 105

IP Patent Invention Licensing 105

Kashishipr

NOVEMBER 3, 2021

Interestingly, in these cases, the trademark owner itself/himself misused the trademark as the generic name of the product in advertising and Patent Applications. ” For combating trademark genericide, conventional trademark enforcement measures have to be coupled with unconventional methods.

Trademark 105

Trademark Branding Brands Branding 105

SpicyIP

AUGUST 14, 2023

Other Posts Timelines under Rule 138 of Patent Rules are to be interpreted strictly and there cannot be any leeway under Rule 49.6 of PCT Regulations, says Delhi High Court The DHC ruled that timelines for filing national phase applications cannot be extended, in light of India’s reservation to the PCT Regulations on this.

Trademark 98

Trademark Registration Art Reporting 98

SpicyIP

MAY 15, 2023

The petitioner is the sole registered proprietor and user of the “Maxgalin” mark, a Schedule H drug, since 2005. 1 applied for the registration of “MGalin” in 2018 with false user data of 7th January 2003, to which the respondent failed to adduce any evidence to rebut the assertion.

Trademark 104

Trademark Registration Cease and Desist IP 104